secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001104659-25-057222
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences receives Nasdaq delisting notice for bid price deficiency; requests hearing
--------------------------------------------------------------------------------

- Nasdaq notified APDN on May 30, 2025 that bid price closed below $1.00 for 32 consecutive business days, violating Listing Rule 5550(a)(2).
- APDN executed a 1-for-15 reverse stock split on June 2, 2025 to address deficiency, but is ineligible for a compliance period due to prior reverse splits.
- Company timely requested a hearing before Nasdaq Hearings Panel on June 6, 2025, which stays any suspension or delisting pending outcome.
- No assurance that the Panel will grant continued listing; shares remain at risk of delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465925057222/0001104659-25-057222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465925057222/tm2517408d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-057222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer